Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of NRT and Bupropion in Smoking Cessation
NCT01048944Phase 4Completed
- Sponsor
- Southern Illinois University Carbondale
- Start
- Jun 2005
- Primary completion
- Jan 2013
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupropion and nicotine patch in nicotine dependence (4 arms), sponsored by Southern Illinois University Carbondale. Primary endpoints: Changes in Log Brain-wave (EEG) Activity at 66 days and Changes in Log of Smoking Withdrawal Scores (Mood, and Depressive Symptoms) at 66 days. Started Jun 2005; status: completed.
02
Drugs
bupropionnicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01048944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048944.